Abstract |
Hormones in physiological doses and under cyclic regime were injected to rats with DMBA-induced mammary tumours. It is demonstrated that 17-alpha-hydroxyprogesterone capronate (HPC) alone administered once every 6 days reduces estradiol receptor (ER) and progesterone receptor (PR) levels and the frequency of R+ tumours. Under the influence of a successive use of HPC and testosterone (TS) the level of PR and the frequency of PR+ tumours were reduced. A high level of ER and PR and a high frequency of R+ tumours were observed after a successive administration of insulin, prednisolone, HPC and TS. All the variants of hormonal influences resulted in an increased life duration of animals, a reduced growth rate, and an increased degree of mammary tumour differentiation.
|
Authors | N S Kartavova, N S Gutnik, D P Burlaka, O I Dasiukevich |
Journal | Eksperimental'naia onkologiia
(Eksp Onkol)
Vol. 8
Issue 1
Pg. 54-8
( 1986)
ISSN: 0204-3564 [Print] Ukraine |
Vernacular Title | Retseptory éstradiola i progesterona v indutsirovannykh DMBA opukholiakh molochnoĭ zhelezy u krys pri tsiklicheskikh gormonal'nykh vozdeĭstviiakh. |
PMID | 3081323
(Publication Type: Comparative Study, English Abstract, Journal Article)
|
Chemical References |
- Hydroxyprogesterones
- Receptors, Estradiol
- Receptors, Estrogen
- Receptors, Progesterone
- Testosterone
- 9,10-Dimethyl-1,2-benzanthracene
- 17-alpha-Hydroxyprogesterone
|
Topics |
- 17-alpha-Hydroxyprogesterone
- 9,10-Dimethyl-1,2-benzanthracene
- Animals
- Cytosol
(analysis, drug effects)
- Female
- Hydroxyprogesterones
(pharmacology)
- Mammary Neoplasms, Experimental
(analysis, chemically induced, mortality)
- Rats
- Receptors, Estradiol
(analysis, drug effects)
- Receptors, Estrogen
(drug effects)
- Receptors, Progesterone
(analysis, drug effects)
- Testosterone
(pharmacology)
- Time Factors
|